John Overdeck’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
John Overdeck's NVS Position: Q2 2026 in Review
John Overdeck reduced its Novartis (NVS) stake by 49% in Q2 2026, selling an estimated $2.03M and leaving 13,992 shares worth $2.19M. The position accounts for ﹤0.01% of the portfolio, ranked #2919.
John Overdeck first reported a position in NVS in Q2 2013 and has held it in 36 quarters since. The position peaked at $170M in Q1 2022. 1,615 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- John Overdeck held 13,992 shares of Novartis worth $2.19M as of Q2 2026.
- John Overdeck sold 13,536 Novartis shares in Q2 2026, an estimated $2.03M.
- Novartis made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #2919 holding.
- John Overdeck first reported a position in Novartis in Q2 2013 and has held it in 36 quarters since.
- John Overdeck's Novartis position peaked at $170M in Q1 2022.
- 1,615 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.